Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)

Frontotemporal lobar degeneration (FTLD) defines a spectrum of heterogeneous neurodegenerative disorders characterized by the progressive deterioration of the frontal and anterior temporal lobes of the brain. FTLD is histopathologically classified according to the presence of neuropathological prote...

Full description

Bibliographic Details
Main Authors: Guinevere F. Lourenco, Michael Janitz, Yue Huang, Glenda M. Halliday
Format: Article
Language:English
Published: Elsevier 2015-10-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996115300164
_version_ 1819159869192667136
author Guinevere F. Lourenco
Michael Janitz
Yue Huang
Glenda M. Halliday
author_facet Guinevere F. Lourenco
Michael Janitz
Yue Huang
Glenda M. Halliday
author_sort Guinevere F. Lourenco
collection DOAJ
description Frontotemporal lobar degeneration (FTLD) defines a spectrum of heterogeneous neurodegenerative disorders characterized by the progressive deterioration of the frontal and anterior temporal lobes of the brain. FTLD is histopathologically classified according to the presence of neuropathological protein aggregates. Two of the major pathologies, FTLD-TDP and FTLD-FUS, are characterized by the abnormal accumulation in cytoplasmic inclusions of RNA-binding proteins (RBPs) — TDP-43 and FUS/TLS, respectively. That suggests that a crucial common downstream pathway leading to cell death might involve the disruption of RNA-based mechanisms. Long noncoding RNAs have emerged as key regulators in the different layers of gene regulation. Increasing evidence suggests that long non-coding RNAs (lncRNAs) may have pivotal biological functions in the brain and, not surprisingly, they have been implicated with neurodegenerative diseases, like Alzheimer's and Parkinson's diseases. Recent studies report that FTLD/ALS-related proteins TDP-43 and FUS/TLS bind lncRNAs, and that several lncRNAs have binding sites for TDP-43 and/or FUS/TLS. These findings raise important questions about how TDP-43 and FUS/TLS pathologies can affect lncRNA-based mechanisms. One alternative is that TDP-43 and FUS/TLS regulate lncRNA transcription or transcript stability. In fact, it has been demonstrated that lncRNAs are dysregulated upon either depletion or unavailability of functional TDP-43 or FUS/TLS in a range of different models and diseases, including post-mortem samples from subjects with FTLD-TDP. The second alternative is that the binding to TDP-43 or FUS/TLS would enable lncRNAs to perform their cellular function. In this case, the unavailability of these RBPs would disrupt functional properties of lncRNAs, without necessarily altering their cellular levels. It has been experimentally demonstrated that the cellular function of some lncRNAs is strictly dependent on the direct binding to TDP-43 or FUS/TLS.
first_indexed 2024-12-22T16:47:24Z
format Article
id doaj.art-c708172f40cf426ab95f11de359d5cb9
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-22T16:47:24Z
publishDate 2015-10-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-c708172f40cf426ab95f11de359d5cb92022-12-21T18:19:42ZengElsevierNeurobiology of Disease1095-953X2015-10-0182445454Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)Guinevere F. Lourenco0Michael Janitz1Yue Huang2Glenda M. Halliday3Neuroscience Research Australia, Sydney, Australia; UNSW Medicine, University of New South Wales, Sydney, AustraliaSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, AustraliaNeuroscience Research Australia, Sydney, Australia; UNSW Medicine, University of New South Wales, Sydney, AustraliaNeuroscience Research Australia, Sydney, Australia; UNSW Medicine, University of New South Wales, Sydney, Australia; Corresponding author at: Neuroscience Research Australia, Barker Street, Randwick 2031, Australia.Frontotemporal lobar degeneration (FTLD) defines a spectrum of heterogeneous neurodegenerative disorders characterized by the progressive deterioration of the frontal and anterior temporal lobes of the brain. FTLD is histopathologically classified according to the presence of neuropathological protein aggregates. Two of the major pathologies, FTLD-TDP and FTLD-FUS, are characterized by the abnormal accumulation in cytoplasmic inclusions of RNA-binding proteins (RBPs) — TDP-43 and FUS/TLS, respectively. That suggests that a crucial common downstream pathway leading to cell death might involve the disruption of RNA-based mechanisms. Long noncoding RNAs have emerged as key regulators in the different layers of gene regulation. Increasing evidence suggests that long non-coding RNAs (lncRNAs) may have pivotal biological functions in the brain and, not surprisingly, they have been implicated with neurodegenerative diseases, like Alzheimer's and Parkinson's diseases. Recent studies report that FTLD/ALS-related proteins TDP-43 and FUS/TLS bind lncRNAs, and that several lncRNAs have binding sites for TDP-43 and/or FUS/TLS. These findings raise important questions about how TDP-43 and FUS/TLS pathologies can affect lncRNA-based mechanisms. One alternative is that TDP-43 and FUS/TLS regulate lncRNA transcription or transcript stability. In fact, it has been demonstrated that lncRNAs are dysregulated upon either depletion or unavailability of functional TDP-43 or FUS/TLS in a range of different models and diseases, including post-mortem samples from subjects with FTLD-TDP. The second alternative is that the binding to TDP-43 or FUS/TLS would enable lncRNAs to perform their cellular function. In this case, the unavailability of these RBPs would disrupt functional properties of lncRNAs, without necessarily altering their cellular levels. It has been experimentally demonstrated that the cellular function of some lncRNAs is strictly dependent on the direct binding to TDP-43 or FUS/TLS.http://www.sciencedirect.com/science/article/pii/S0969996115300164Frontotemporal lobar degenerationTDP-43FUS/TLSLong noncoding RNANeurodegeneration
spellingShingle Guinevere F. Lourenco
Michael Janitz
Yue Huang
Glenda M. Halliday
Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
Neurobiology of Disease
Frontotemporal lobar degeneration
TDP-43
FUS/TLS
Long noncoding RNA
Neurodegeneration
title Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
title_full Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
title_fullStr Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
title_full_unstemmed Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
title_short Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
title_sort long noncoding rnas in tdp 43 and fus tls related frontotemporal lobar degeneration ftld
topic Frontotemporal lobar degeneration
TDP-43
FUS/TLS
Long noncoding RNA
Neurodegeneration
url http://www.sciencedirect.com/science/article/pii/S0969996115300164
work_keys_str_mv AT guinevereflourenco longnoncodingrnasintdp43andfustlsrelatedfrontotemporallobardegenerationftld
AT michaeljanitz longnoncodingrnasintdp43andfustlsrelatedfrontotemporallobardegenerationftld
AT yuehuang longnoncodingrnasintdp43andfustlsrelatedfrontotemporallobardegenerationftld
AT glendamhalliday longnoncodingrnasintdp43andfustlsrelatedfrontotemporallobardegenerationftld